1. The Merck Index. 13a edição, 2001. pág. 8240.
2. Journal of Physiology and Pharmacology 2005, 56, suppl 1, 51.69.
3. Yeung et al, Modulation of kB-dependent transcription and cell survival by the SIRT1
deacetylase, The EMBO J. 2004; 23:2364-2380.
4. Proc. Natl. Acad. Sci. USA. Vol 94, pp.14138 – 14143, December 1997. Resveratrol, a
polyphenolic compound found in grapes an wine, is an agonist for the estrogen receptor.
5. Carrizzo A et al. Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism. Hypertension, August 2013.
6. Nordon D.G et al. Perda cognitiva em idosos. Rev.Fac.Ciênc.Med.Sorocaba, v.11, 2009.
7. Witte A.V et al. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. The Journal of Neuroscience, June 2014.
8. Séfora-Souza M, de Angelis-Pereira M.C. Mecanismos moleculares da ação antiinflamatória
e antioxidante de polifenóis de uvas e vinho tinto na aterosclerose. Rev.Bras.Pl.Med., Campinas,
2013.
9. Kennedy D.O et al. Effects of resveratrol on cerebral blood flow variables and cognitive
performance in humans: a double-blind, placebo-controlled, crossover investigation. The American Journal of Clinical Nutrition, 2010.
10. Farris P et al. Resveratrol: a unique antioxidant offering a multi-mechanistic approach for
treating aging skin. Journal of Drugs in Dermatology, 2013.
11. Buonocore D et al. Resveratrol-procyanidin blend: nutraceutical and antiaging efficacy
evaluated in a placebo-controlled, double-blind study. Clinical, Cosmetic and Investigational
Dermatology, 2012.
12. Ornstrup M.J et al. Resveratrol increases bone mineral density and bone
alkaline phosphatase in obese men: a randomized placebo-controlled trial. J.Clin.Endocrinol.Metab.,
December 2014.